Safety and immunogenicity of a plant-produced recombinant hemagglutinin-based influenza vaccine (HAI-05) derived from A/Indonesia/05/2005 (H5N1) influenza virus: a phase 1 randomized, double-blind, placebo-controlled, dose-escalation study in health
about
Vaccines for preventing influenza in healthy adultsPlant-based vaccines for animals and humans: recent advances in technology and clinical trialsPlant-produced candidate countermeasures against emerging and reemerging infections and bioterror agentsAdvancements in the development of subunit influenza vaccinesPurification and immunogenicity of hemagglutinin from highly pathogenic avian influenza virus H5N1 expressed in Nicotiana benthamiana.Clinical vaccine development for H5N1 influenza.A Perspective on the Development of Plant-Made Vaccines in the Fight against Ebola VirusBroad and efficient control of major foodborne pathogenic strains of Escherichia coli by mixtures of plant-produced colicins.Single-dose monomeric HA subunit vaccine generates full protection from influenza challenge.Influenza vaccines: a moving interdisciplinary field.Early vaccine availability represents an important public health advance for the control of pandemic influenza.Plant-based vaccines against viruses.A plant-produced Pfs25 VLP malaria vaccine candidate induces persistent transmission blocking antibodies against Plasmodium falciparum in immunized mice.Plant-derived pharmaceuticals for the developing world.Recent developments in therapeutic protein expression technologies in plants.Advances and challenges in the development and production of effective plant-based influenza vaccines.Heterologous protein production in plant systems.Good manufacturing practices production of a purification-free oral cholera vaccine expressed in transgenic rice plants.Plant-Produced Subunit Vaccine Candidates against Yellow Fever Induce Virus Neutralizing Antibodies and Confer Protection against Viral Challenge in Animal Models.Humoral and cell-mediated immune responses to H5N1 plant-made virus-like particle vaccine are differentially impacted by alum and GLA-SE adjuvants in a Phase 2 clinical trial.Production of complex viral glycoproteins in plants as vaccine immunogensAluminum salts as an adjuvant for pre-pandemic influenza vaccines: a meta-analysis
P2860
Q24197955-17A2EED0-BEC5-4B45-827B-C1F60B9B7E03Q26775788-19842165-602D-4980-A05B-4AF3B2155F62Q26783107-0E729832-DB35-499E-B53D-220018619441Q27010100-2A2A6754-24EB-456E-AE5F-2656297098A3Q30151541-89ED640D-6EB3-4778-93A4-CA8FA406EE9FQ30222083-99378E45-B511-4B32-B5C8-1D4735E6717AQ30235073-6320E2FA-51A8-4198-98EB-DE0ABB740B34Q30316197-D9943B95-BDB8-4351-8219-93823914E917Q30357409-D1ED389C-1DF1-44E6-BBDF-81E9057A8C08Q30367695-0615017F-1746-4B81-9771-B7C6C17B0585Q30374481-B27D6C3D-F20A-4861-85A0-DA78E35B8F0FQ34687464-1EDB2645-596F-45B1-B053-9ED4DA8C60CAQ35048518-139FC1A3-6EC7-4B14-9B35-21790EACD675Q38121856-D4A55EB2-0266-4312-86C3-410DC703EED1Q38261152-60762F46-6302-431D-8397-958BDF61E8ABQ38285425-0E7AA722-BD45-4595-9A9A-FD07F4BED3D9Q38992414-49236DBD-6999-48AB-AA45-B690814E45FFQ40217465-EEEF180D-6E0A-4006-9BF2-8F76EFD890AAQ46634823-B4DD28CE-D4FE-4495-B5B9-D94E008B31D4Q47547355-8474F659-04E6-4DDB-83D1-4C5795B5F5B9Q56398263-8636622E-482C-4F6B-81F1-583F76C82BBDQ57094173-4A9B2DB1-A661-4BDE-BC00-0AB07057D525
P2860
Safety and immunogenicity of a plant-produced recombinant hemagglutinin-based influenza vaccine (HAI-05) derived from A/Indonesia/05/2005 (H5N1) influenza virus: a phase 1 randomized, double-blind, placebo-controlled, dose-escalation study in health
description
2012 nî lūn-bûn
@nan
2012 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Safety and immunogenicity of a ...... ose-escalation study in health
@ast
Safety and immunogenicity of a ...... ose-escalation study in health
@en
Safety and immunogenicity of a ...... ose-escalation study in health
@nl
type
label
Safety and immunogenicity of a ...... ose-escalation study in health
@ast
Safety and immunogenicity of a ...... ose-escalation study in health
@en
Safety and immunogenicity of a ...... ose-escalation study in health
@nl
prefLabel
Safety and immunogenicity of a ...... ose-escalation study in health
@ast
Safety and immunogenicity of a ...... ose-escalation study in health
@en
Safety and immunogenicity of a ...... ose-escalation study in health
@nl
P2093
P2860
P356
P1433
P1476
Safety and immunogenicity of a ...... ose-escalation study in health
@en
P2093
Brian J Green
George Moonsammy
Jessica A Chichester
R Mark Jones
Stephen J Streatfield
Vidadi Yusibov
P2860
P304
P356
10.3390/V4113227
P577
2012-11-19T00:00:00Z